TEVA PHARMACEUTICAL-SP ADR (TEVA)       10.5  -0.04 (-0.38%)

10.5  -0.04 (-0.38%)

US8816242098 - ADR

TEVA PHARMACEUTICAL-SP ADR10.5

NYSE:TEVA (2/1/2023, 9:14:09 AM)-0.04 (-0.38%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Pharmaceuticals

Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend

Overview
Earnings (Last) 11-03 2022-11-03/dmh Earnings (Next) 02-07 2023-02-07
Ins Owners 0.45% Inst Owners 47.19%
Market Cap 11.66B Shares 1.11B
PE 4.02 Fwd PE 4.01
Dividend Yield N/A Analysts 80
IPO 01-01 1951-01-01

Stock Screener Links

Screen Image

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

TEVA Daily chart

Company Profile

Teva Pharmaceutical Industries Ltd. engages in the development and production of medicines. The firm operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

Company Info

TEVA PHARMACEUTICAL-SP ADR

5 Bazel St, P O B 3190

Petah Tikva 49131

P: 97239267267.0

CEO: Kare Schultz

Employees: 34713

Website: http://www.tevapharm.com

TEVA News

News Image2 days ago - Seeking AlphaEvoke stock rises on filing of dismissal in nasal spray Gimoti's patent infringement case

Evoke Pharma (EVOK) stock rose ~4% on Monday after the company said that a joint stipulation of dismissal was filed in the Gimoti's patent infringement case in the U.S

News Image5 days ago - Investor's Business DailyStock Market Rally Powers Higher Amid Big Earnings From Tesla, Boeing, Microsoft, American Express: Weekly Review

Stocks reacted well to uneven earnings and economic reports.

News Image6 days ago - Market News VideoInteresting TEVA Put And Call Options For March 10thNews Image6 days ago - The Motley FoolDown 30% in a Day, Is Catalyst Pharmaceuticals Doomed?

Things aren't as bad as they might seem.

News Image6 days ago - The Motley Fool6 Great Stocks to Buy in 2023 and Hold Forever

I own all six great businesses and don't plan to sell a single share.

News Image7 days ago - Investor's Business DailyHow Former IBD 50 Leader Catalyst Pharma Is Trying To Claw Back From A 29% Setback

Catalyst is adding to its portfolio with a $160 million deal.

TEVA Twits

Here you can normally see the latest stock twits on TEVA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example